Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications.
Christian BattipagliaLia FelicielloAlessandro D GenazzaniFabio FacchinettiGiovanni GrandiPublished in: Expert opinion on drug metabolism & toxicology (2023)
E4/DRSP-based COC has shown high tolerability, safety and satisfaction and may represent a viable choice in young girls in need of oral contraception and pill users who suffer from high cholesterol, breast tenderness or water retention. Moreover, this new COC shows higher scheduled bleeding rate compared to other pills containing natural estrogens. All the data are reassuring, permitting long-term use.